Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
regenerative medicine
Biotech
Pfizer vet takes CEO post at new, phase 3-ready biotech
Months after leaving Pfizer, Suneet Varma has taken the CEO position at the newly created inflammation and immunology startup Intent Biologics.
Nick Paul Taylor
Sep 9, 2025 10:03am
FDA approves Humacyte’s off-the-shelf artery for trauma repairs
Dec 23, 2024 10:36am
Aurion's regenerative med improves vision in phase 1/2 trial
Dec 18, 2024 7:00am
ProKidney halts ph. 3 trial not needed for cell therapy approval
Sep 3, 2024 8:55am
'Fascinating and completely unexpected': Tiny robots fix neurons
Dec 4, 2023 8:00am
First live chimeric monkey is technical feat, ethics concern
Nov 10, 2023 7:05am